All lobbying filings

AGILON HEALTH, INC.

AGILON HEALTH, INC. filed a Q2 report for AGILON HEALTH, INC. on July 17, 2026.

Lobbying for AGILON HEALTH, INC. · Health care provider

All filings by AGILON HEALTH, INC. · Everything AGILON HEALTH, INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 17, 2026

Expenses

$100,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Texas

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Medicare Shared Savings Program (MSSP) and SCO REACH Model; LEAD Model; MA data sharing; physician reimbursement and Medicare and CHIP Reauthorization Act (MACRA)-related policies (PL 114-10), including APM bonus payments; HR.8129, To amend title XVIII of the Social Security Act to establish a full risk ACO program, full-risk legislation; and related CMS innovation and payment model activities through CMMI.

Bills named in this filing 1

H.R. 8129
To amend title XVIII of the Social Security Act to establish a full risk ACO program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.